FloTrac
DeviceStroke Volume has been maintained at 90% of the maximal Stroke Volume as in NICE protocol 2011
NCT Number: NCT03023618
In this "before and after" study we will investigate the potential benefit on postoperative outcomes of a guided fluid therapy with a stroke volume optimization . The NICE protocol has been applied by means of EV1000 monitor and arterial waveform analysis ( Flotrac - Edwards). In the postoperative period overall complications, as well as exitus , will be analyzed and compared with those of a control group underwent the same surgical interventions, with a standard hemodynamic monitoring.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Stroke Volume has been maintained at 90% of the maximal Stroke Volume as in NICE protocol 2011
Time frame: up to 30 days postoperatively
Time frame: an average of 30 days
Time frame: an average of 12 hours
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Effect Of Stroke Volume Optimization On Complication Rate Of Patients Undergoing Pancreatic Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00624494
Arterial Occlusive Diseases, Arteriosclerosis
Arkhangelsk, Russia
View Trial DetailsNCT03245372
Fluid Therapy, Goal Directed Therapy
Seville, Spain
View Trial DetailsNCT04814966
Complications, Goal Directed Therapy
Kiel, Deutschland (deu), Germany
View Trial DetailsNCT03012919
Active Decision Support System, Feasibility
View Trial Details